Heart inflammation in Israel

Global

India

Cases, + 352,991 + 323,144 = 17,640,000

Deaths, + 2,800 = 197,894

Thriving black market

Underprepared governments

US allowing exports of vaccine components

US, 60 million AZ doses for export

US sends medical supplies

No intellectual property wavers

UK sends medical aid

Spain sends medical aid

Germany sending in a few days

ONS, week ending 16th April

England

Prevalence, 90,000 people (0.17%) in the community

(W/E 10th April, 112,600)

One in 610 people

Wales

Prevalence, 3,600 people (0.12%)

(W/E 10th April, 3,300)

One in 840 people

Northern Ireland

Prevalence, 2,800 people (0.15%)

(W/E 10th April, 2,600)

One in in 660 people

Scotland

Prevalence, 9,300 people (0.18%)

(W/E 10th April, 10,500)

One in 560 people

England and Wales, CoViD deaths 3.5% of all deaths in the week

Now

United States

J&J/Janssen Update

CDC and the U.S. Food and Drug Administration (FDA) recommend use

Reports suggest an increased risk of a rare adverse event called thrombosis with thrombocytopenia syndrome (TTS)

Nearly all reports, adult women younger than 50 years old

Potential benefits outweigh known and potential risks

Women younger than 50 years old should be aware

there are other COVID-19 vaccine options available

For three weeks after receiving the vaccine

lookout for possible symptoms of a blood clot with low platelets

Severe or persistent headaches or blurred vision

Shortness of breath

Chest pain

Leg swelling

Persistent abdominal pain

Easy bruising or tiny blood spots under the skin beyond the injection site

Pfizer, Israel

Channel 12 reported Friday

More than 5 million people vaccinated

62 recorded cases of myocarditis

56 of those cases came after the second shot

Most of the affected were men under 30.

60 of the patients were treated and released from hospital in good condition

2 deaths (22-year-old woman and a 35-year-old man)

details had also been sent to the US FDA and CDC, who were also investigating

one possible reason for lack of similar findings in other countries was the low rate of vaccinations among young people

There is specific concern regarding the frequency of the occurrence observed in men under 30 in the days immediately after the second shot

At this stage, according to initial findings that still need to be verified, there is an impression that the number (of cases) is higher than would be expected, especially for those under 30

Overall findings, 1-in-100,000

Aged 16 – 30 years, 1-in-20,000

We cannot yet tell if there are more cases than normal or if there are similar numbers annually and the proximity is just a coincidence.

Efforts to collect more data are continuing

Israel, children aged 12-15, when US Food and Drugs Administration approves

Health Ministry Director-General Chezy Levi

Once that age group has been vaccinated, the country will reach herd immunity

Therefore no need to vaccinate younger children

Vaccine choice, may be:

Younger women, Pfizer

Younger men, Janssen